Assignee
HIKMA PHARMACEUTICALS USA INC
US·20 granted patents·15 pending applications·39 citations·filing 2018–2025
Top patents by PatentIndex Score
35 records- 0197US11628139B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Apr 18, 2023·7 cites·12 claims
- 0296US11617713B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Apr 4, 2023·4 cites·18 claims
- 0396US11135155B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Oct 5, 2021·8 cites·19 claims
- 0495US11975096B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted May 7, 2024·2 cites·19 claims
- 0595US10973814B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2019·Granted Apr 13, 2021·10 cites·12 claims
- 0690US11684573B1Vasopressin liquid formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2020·Granted Jun 27, 2023·3 cites·39 claims
- 0788US2025288640A1Glycopeptide compositionsHIKMA PHARMACEUTICALS USA INC·Filed 2024·Application pending·0 cites
- 0887US11744811B2Methods of stabilizing epinephrineHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Sep 5, 2023·1 cites·19 claims
- 0985US12011440B2Ready-to-administer hydromorphone formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2022·Granted Jun 18, 2024·2 cites·18 claims
- 1084US12414915B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2023·Granted Sep 16, 2025·0 cites·1 claims
- 1184US12161690B2Glycopeptide compositionsHIKMA PHARMACEUTICALS USA INC·Filed 2023·Granted Dec 10, 2024·0 cites·19 claims
- 1284US11571384B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Feb 7, 2023·2 cites·24 claims
- 1377US12178903B1Liquid composition comprising glucoseHIKMA PHARMACEUTICALS USA INC·Filed 2024·Granted Dec 31, 2024·0 cites·13 claims
- 1477US2023390218A1Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 1575US2025332092A1Liquid composition comprising glucoseHIKMA PHARMACEUTICALS USA INC·Filed 2024·Application pending·0 cites
- 1674US2025205149A1Phenylephrine hydrochloride ready-to-use solutionHIKMA PHARMACEUTICALS USA INC·Filed 2025·Application pending·0 cites
- 1773US12257342B2Phenylephrine hydrochloride ready-to-use solutionHIKMA PHARMACEUTICALS USA INC·Filed 2022·Granted Mar 25, 2025·0 cites·21 claims
- 1872US12527787B2Ready-to-administer hydromorphone formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2024·Granted Jan 20, 2026·0 cites·20 claims
- 1971US2025127846A1Daptomycin formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2024·Application pending·0 cites
- 2070US11771663B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Oct 3, 2023·0 cites·16 claims
- 2168US11517525B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Dec 6, 2022·0 cites·16 claims
- 2268US10617637B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Apr 14, 2020·0 cites·14 claims
- 2365US2021276749A1System and method for purging oxygen from medical vialsHIKMA PHARMACEUTICALS USA INC·Filed 2021·Application pending·0 cites
- 2464US10973781B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2019·Granted Apr 13, 2021·0 cites·4 claims
- 2562US2025009728A1Benzimidazole derivatives compositionsHIKMA PHARMACEUTICALS USA INC·Filed 2024·Application pending·0 cites
- 2660US2023240998A1Tofacitinib extended release formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2022·Application pending·0 cites
- 2759US2024197621A1Buffered Lidocaine Injectable Formulations and Methods for Making SameHIKMA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 2857US2024238275A1Hydromorphone formulations for multi-dose productsHIKMA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 2954US2025295727A1Stable, ready-to-administer aqueous formulations of dalbavancinHIKMA PHARMACEUTICALS USA INC·Filed 2022·Application pending·0 cites
- 3053US12295932B2Succinylcholine chloride prefilled syringeHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted May 13, 2025·0 cites·32 claims
- 3153US11433072B1Oral dosage forms of ibrutinibHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Sep 6, 2022·0 cites·28 claims
- 3253US2023137986A1Succinylcholine Chloride Prefilled SyringeHIKMA PHARMACEUTICALS USA INC·Filed 2021·Application pending·0 cites
- 3348US2026021060A1Ready-to-administer product comprising a norepinephrine formulationHIKMA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 3443US2023310749A1Rocuronium bromide prefilled syringeHIKMA PHARMACEUTICALS USA INC·Filed 2022·Application pending·0 cites
- 3538US2020237695A1Levothyroxine liquid formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HIKMA PHARMACEUTICALS USA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →